Advanced Breast Cancer Completed Phase 2 Trials for Dasatinib (DB01254)

Also known as: Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Ca breast

IndicationStatusPhase
DBCOND0031019 (Advanced Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00754325Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase InhibitorTreatment
NCT00546104Phase II Dasatinib Study in Advanced Breast CancerTreatment